After decades of limited research and legal roadblocks to medical and recreational use, psychedelic drugs are rapidly remerging as treatments of interest in psychiatry. We interviewed two experts in the field.
Even before the COVID-19 pandemic began, concerning mental health trends and major treatment gaps were noted among adolescents. We spoke with Cécile Rousseau, MD, researcher, psychiatrist, and professor in the division of social and transcultural psychiatry at McGill University in Montreal, Canada about the impact of the COVID-19 pandemic on adolescent mental health.
Experts examine medication management in older adults, including the use of antidepressants for patients with Alzheimer disease and the dangers of opioid prescribing.
The COVID-19 pandemic led to an exacerbation of pre-existing hardships and disparities in many vulnerable populations, including individuals affected by intimate partner violence. We interviewed experts in the field to learn more about this issue and how clinicians may best assist affected individuals.
To learn more about the potential role of cannabinoids in the management of sleep disorders, we interviewed Aleksandra M. Kwasnik, MD, who recently coauthored a review on the topic.